Lineage Cell Therapeutics
-
Ticker
LCTX
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Carlsbad, California
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its proprietary cell-based therapy platform and associated development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally-differentiated human cells from its pluripotent and
…More progenitor cell starting materials. These differentiated cells are developed either to replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer.
Lineage Cell Therapeutics
Most Recent Responsibility Report
MOST RECENT
2022 Corporate Sustainability Report
Report Locked. Lineage Cell Therapeutics has reached its limit for free report views.
Our service enables potential investors to review the most recent and archived Lineage Cell Therapeutics Sustainability Report, Lineage Cell Therapeutics Corporate Social Responsibility Report, Lineage Cell Therapeutics CSR Report, Lineage Cell Therapeutics Corporate Responsibility, Lineage Cell Therapeutics CR Report, Lineage Cell Therapeutics Citizenship Report, Lineage Cell Therapeutics ESG Report, and Lineage Cell Therapeutics Environmental Report online.